# Safety and Immunogenicity Study of Rift Valley Fever Vaccine

> **NCT00584194** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 278 (actual)

## Conditions studied

- Rift Valley Fever

## Interventions

- **BIOLOGICAL:** TSI-GSD 200 RVF Vaccine

## Key facts

- **NCT ID:** NCT00584194
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584194, "Safety and Immunogenicity Study of Rift Valley Fever Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00584194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*